Barry A. Singer

Barry Singer practices at Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health.

Barry Singer's NPI, 1932210671, was assigned on August 31, 2006. Barry Singer graduated from Columbia University College of Physicians and Surgeons in 1992. Barry Singer holds Missouri license 119581.

Barry Singer's primary practice is Missouri Baptist Medical Center, at 3015 N Ballas Rd, Saint Louis, MO 63131 in St. Louis County. The practice phone is (314) 996-5000.

Barry Singer's primary practice is Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health. Barry Singer is also affiliated with Barnes-Jewish Hospital. The medical group on file is BJC Medical Group. Dmand AI also links Barry Singer to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Barry Singer practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Barry Singer's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Barry Singer is licensed in Missouri.

CMS data shows 759 Medicare services from Barry Singer across 5 procedure codes in 2024, for 335 Medicare patients. Medicare paid $54,950 for them.

CMS counts 335 Medicare patients who saw Barry Singer in 2024. The largest group is 65 to 74, with 133 patients. 61% of them have high blood pressure, and 59% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Barry Singer's median patient age at 60, with 72% women.

In 2024, Barry Singer wrote 6,760 Medicare Part D claims for 554 patients. 85% of them were for generic drugs. CMS names the drug for 6,490 of them, across 86 drugs with 11 or more claims each, at $7,164,833 in total drug cost. In 2023, CMS named 5,888 claims across 90 drugs.

Barry Singer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Barry Singer as offering telehealth.

Dmand AI links 27 papers to Barry Singer, published from 2012 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting and Immunosuppressive Agents. Barry Singer has published most often in Neurol Ther. Barry Singer's most frequent co-authors are Aaron Lee Boster, MD, Fernando Dangond, MD and Ann Doan Bass, MD.

Dmand AI links Barry Singer to 2 clinical trials. Conditions studied include Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis. Genzyme, a Sanofi Company sponsors the most, 2. Open Payments lists research payments to Barry Singer that name 2 trials.

CMS Open Payments shows 2,731 general payments to Barry Singer from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 56% of the total. Sanofi and Genzyme US Companies paid the most, $837,779. It also lists 195 research payments totaling $108,095 from 2016 to 2025, naming 2 clinical trials.

Barry Singer graduated from Columbia University College of Physicians and Surgeons in 1992.